Wenpei Liu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.

Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.

Journal: Fundamental & clinical pharmacology

Published: October 24, 2022

Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.

Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.

Journal: Pharmacogenomics

Published: April 26, 2022

The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study.

The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study.

Journal: Therapie

Published: April 06, 2022

The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.

The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.

Journal: Journal of clinical pharmacy and therapeutics

Published: March 25, 2022

A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.

A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.

Journal: Journal of clinical pharmacy and therapeutics

Published: April 21, 2021

NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.

NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.

Journal: Pharmacology research & perspectives

Published: September 11, 2020

Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.

Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: March 09, 2020

Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.

Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.

Journal: Journal of clinical pharmacy and therapeutics

Published: February 08, 2020

Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.

Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.

Journal: BMJ open

Published: April 01, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026